Innate immune dysregulation in multisystem inflammatory syndrome in children (MIS-C)

Sci Rep. 2023 Sep 30;13(1):16463. doi: 10.1038/s41598-023-43390-6.

Abstract

MIS-C is a systemic inflammation disorder with poorly characterised immunopathological mechanisms. We compared changes in the systemic immune response in children with MIS-C (n = 12, 5-13 years) to healthy controls (n = 14, 5-15 years). Analysis was done in whole blood treated with LPS. Expression of CD11b and Toll-like receptor-4 (TLR4) in neutrophils and monocytes were analysed by flow cytometry. Serum cytokines (IL-1β, IL-2, IL-6, IL-8, IL-10, IL-Ira, TNF-α, TNF-β, IFN-Υ, VEGF, EPO and GM-CSF) and mRNA levels of inflammasome molecules (NLRP3, ASC and IL-1β) were evaluated. Subpopulations of lymphocytes (CD3+, CD19+, CD56+, CD4+, CD8+, TCR Vδ1+, TCR Vδ2+) were assessed at basal levels. Absolute counts of neutrophils and NLR were high in children with MIS-C while absolute counts of lymphocytes were low. Children with MIS-C had increased levels of IL-6, IL-10, TNF-β and VEGF serum cytokines at the basal level, and significantly increased TNF-β post-LPS, compared to controls. IL-1RA and EPO decreased at baseline and post-LPS in MIS-C patients compared to controls. The percentage of CD3+ cells, NK cells and Vδ1 was lower while B cells were higher in children with MIS-C than in controls. Dysregulated immune response in children with MIS-C was evident and may be amenable to immunomodulation.

MeSH terms

  • Child
  • Cytokines / metabolism
  • Humans
  • Immunity, Innate
  • Interleukin-10* / metabolism
  • Interleukin-6
  • Lipopolysaccharides
  • Lymphotoxin-alpha*
  • Receptors, Antigen, T-Cell
  • Vascular Endothelial Growth Factor A

Substances

  • Interleukin-10
  • Lymphotoxin-alpha
  • Lipopolysaccharides
  • Interleukin-6
  • Vascular Endothelial Growth Factor A
  • Cytokines
  • Receptors, Antigen, T-Cell

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related